Researchers describe the symptom profiles of respiratory viral infections.
AbbVie’s stumble, Amgen’s tumble and more election fallout
Why are AbbVie executives feeling the M&A blues? What does it take to slice $12 billion from Amgen’s market value? And why are STAT’s D.C.